| Title | Guidance: Considerations for Rescinding Breakthrough Therapy Designation |
| ToC Doc | Considerations for Rescinding Breakthrough Therapy Designation |
| Docket Number | 2022-13528 |
| Type | Notice |
| Subject | Guidance: Considerations for Rescinding Breakthrough Therapy Designation |
| Publication Date | 2022-06-24 |
| Last Updated Date | 2022-06-23 08:15:08 -0400 |
| Last Public Inspection | 2022-06-23 |
| Filed At | 2022-06-23T08:45:00.000-04:00 |
| 2022-13528_PI.pdf (79511 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 6 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...